FDA Skeptical of Benefits From Experimental ALS Drug

    0
    145

    Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig’s disease, after months of lobbying by patient advocates urging approval.

    Advertisment
    Previous articleLapsus$ Found a Spreadsheet of Passwords as They Breached Okta, Documents Show
    Next articleGlobal Science Project Links Android Phones With Satellites To Improve Weather Forecasts

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here